SAR445514

· Sanofi

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for SAR445514, covering 2025-06-12 to 2025-06-12. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Investigate Safety and Efficacy With SAR445514 in Participants With Relapsed/Refractory Multiple Myeloma (RRMM) and Relapsed/Refractory Light-chain Amyloidosis (RRLCA) [Phase 1, Phase 2]

See pricing